|
ENTPD4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.91038999999282E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.444100E-04 |
| Normal-vs-Stage2 |
2.41669999999639E-05 |
| Normal-vs-Stage3 |
1.17420000000923E-06 |
| Normal-vs-Stage4 |
1.102170E-03 |
| Stage1-vs-Stage2 |
9.064200E-02 |
| Stage1-vs-Stage3 |
5.436100E-02 |
| Stage1-vs-Stage4 |
5.231400E-01 |
| Stage2-vs-Stage3 |
9.912000E-01 |
| Stage2-vs-Stage4 |
5.000000E-01 |
| Stage3-vs-Stage4 |
4.404600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.41219999999043E-05 |
| Normal-vs-AfricanAmerican |
8.379200E-03 |
| Normal-vs-Asian |
1.098950E-03 |
| Caucasian-vs-AfricanAmerican |
9.390600E-01 |
| Caucasian-vs-Asian |
9.983400E-01 |
| AfricanAmerican-vs-Asian |
9.428600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.91250000012045E-07 |
| Normal-vs-Female |
1.593170E-04 |
| Male-vs-Female |
7.561600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.875800E-03 |
| Normal-vs-Age(41-60Yrs) |
3.58270000000438E-07 |
| Normal-vs-Age(61-80Yrs) |
3.51029999999808E-05 |
| Normal-vs-Age(81-100Yrs) |
4.762000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.976060E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.231180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.032800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.710200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.341000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.994400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.653440E-01 |
| Classical-VS-Follicular |
8.497500E-02 |
| Classical-VS-Other |
2.052600E-01 |
| Classical-VS-Normal |
2.411900E-04 |
| Tall-VS-Follicular |
9.905000E-01 |
| Tall-VS-Other |
5.780800E-01 |
| Tall-VS-Normal |
4.405000E-04 |
| Follicular-VS-Other |
6.823800E-01 |
| Follicular-VS-Normal |
1.779580E-04 |
| Other-VS-Normal |
1.059880E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.67270000020581E-07 |
| Normal-vs-N1 |
3.186000E-04 |
| N0-vs-N1 |
7.773000E-01 |
|
|
